‘Alternative Pathway’ Products Are Key New Challenge For FDA, Woodcock Says

 
• By Ramsey Baghdadi
  
alternate pathways
Some sponsors are trying to find their ways around FDA regulation. • Source: Alamy

More from Approval Standards

More from Pathways & Standards